Iovance Biotherapeutics : 2022 Annual Report : vimarsana.com

ANNUAL REPORT


2 0 2 2





D E A R S H A R E H O L D E R S :


2022 was a pivotal year for...

Related Keywords

United States , Delaware , Washington , California , San Carlos , American , America , Iovance Biotherapeutics , Frederickg Vogt , Exchange Commission , Iovance Cell Therapy Center , Society For Immunotherapy Of Cancer , Iovance Biotherapeutics Inc , Securities Exchange , Nasdaq Stock Market , Incorporated By Reference , Incorporation Or Organization , National Cancer Institute , Drug Administration , Annual Meeting , Non Small Cell Lung , Cervical Cancers , African American , General Counsel , Mark One , Exact Name , Its Charter , Principal Executive Offices , Zip Code , Telephone Number , Including Area Code , Each Class , Securities Exchange Act , Interactive Data File , Regulations T , Sarbanes Oxley Act , Exchange Act , Annual Report , Proxy Statement , Common Equity , Related Stockholder Matters , Issuer Purchases , Equity Securities , Financial Condition , Qualitative Disclosures About Market Risk , Supplementary Data , Financial Disclosure , Executive Officers , Corporate Governance , Certain Beneficial Owners , Related Transactions , Director Independence , Accounting Fees , Financial Statements Schedules , Looking Statements , Market Data , Biologics License Application ,